This activity is certified for 0.75 AOA 1-A Credit. Recorded October 24, 2020. Identify the at risk groups for COVID-19 infection, mortality, and morbidity and the common clinical manifestation and clinical course for patients with COVID-19 infection; Describe the role of the systemic anti-inflammatory response syndrome (SIRS) in generating the “cytokine storm” and its role in acute kidney injury.

This course is certified for 52 AOA Category 1A CME credits. Recordings from the 2020 ACOI Annual Convention and Scientific Sessions, held October 21 - October 24, 2020.

This activity is certified for 1.25 AOA 1-A Credit. Recorded October 23, 2020. Review the current burden of gout (and hyperuricemia). Diagnostic strategies appropriate for primary care physicians are presented as well as strategies of “treating to target” and “treating to avoid symptoms.” The role of urate-lowering pharmacotherapy and lifestyle management and criteria for referral to a rheumatologist are addressed. Recommendations for the management of gout in patients with common comorbidities such as CVD and diabetes.

This activity is certified for .75 AOA 1-A Credit. Recorded October 23, 2020. Brief review of CKD burden in the US and an overview of cardiorenal syndrome. The effects of SGLT2 inhibitors on renal outcomes will be summarized. Explore the potential mechanisms by which these medications exert their renoprotective effects. Review completed and on-going CKD trials with SGLT2 inhibitors.

This activity is certified for 0.75 AOA 1-A Credit. Recorded October 23, 2020. Explore the implications of CKD, ESRD, and renal transplantation for women’s reproductive physiology and healthcare